About Credence MedSystems
Credence MedSystems is a company based in Menlo Park (United States) founded in 2011 by Dan Thayer.. Credence MedSystems has raised $112.61 million across 10 funding rounds from investors including Novartis, Molex and Gates Foundation. Credence MedSystems offers products and services including Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System. Credence MedSystems operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Cellectar Biosciences and Sixfold Bioscience, among others.
- Headquarter Menlo Park, United States
- Founders Dan Thayer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Credence Medsystems, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$112.61 M (USD)
in 10 rounds
-
Latest Funding Round
$12.67 M (USD), Series D
Dec 17, 2024
-
Investors
Novartis
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Credence MedSystems
Credence MedSystems offers a comprehensive portfolio of products and services, including Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Syringe for safe dosing and usability in pharmaceutical applications.
Facilitates delivery of complex drug formulations with ease.
Enables precise injections for specialized medical needs.
Provides data capture for enhanced clinical trial monitoring.
Unlock access to complete
Funding Insights of Credence MedSystems
Credence MedSystems has successfully raised a total of $112.61M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $12.67 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $12.7M
-
First Round
First Round
(24 Sep 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series D - Credence MedSystems | Valuation |
investors |
|
| Sep, 2021 | Amount | Series D - Credence MedSystems | Valuation | Molex , Novartis |
|
| Jan, 2021 | Amount | Series C - Credence MedSystems | Valuation | Novartis |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Credence MedSystems
Credence MedSystems has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Novartis, Molex and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Communication equipment manufacturer
|
Founded Year | Domain | Location | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Credence MedSystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Credence MedSystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Credence Medsystems Comparisons
Competitors of Credence MedSystems
Credence MedSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Cellectar Biosciences and Sixfold Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Phospholipid drug conjugates for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Credence Medsystems
Frequently Asked Questions about Credence MedSystems
When was Credence MedSystems founded?
Credence MedSystems was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Credence MedSystems located?
Credence MedSystems is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Who is the current CEO of Credence MedSystems?
Jeff Shanley is the current CEO of Credence MedSystems.
Is Credence MedSystems a funded company?
Credence MedSystems is a funded company, having raised a total of $112.61M across 10 funding rounds to date.
What does Credence MedSystems do?
Credence Medsystems manufactures and sells drug delivery technologies and prefilled pharmaceuticals. Its product portfolio includes Companion staked needle syringe, companion Luer syringe, companion dual chamber reconstitution safety syringe systems.
Who are the top competitors of Credence MedSystems?
Credence MedSystems's top competitors include Insulet, Lyra Therapeutics and Halozyme.
What products or services does Credence MedSystems offer?
Credence MedSystems offers Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System.
Who are Credence MedSystems's investors?
Credence MedSystems has 3 investors. Key investors include Novartis, Molex, and Gates Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.